Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Global - Population 60 Years or Above (Billion), 2015, 2030 & 2050
Figure 5-1: Global - Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 6-1: Global - Psoriasis Drugs Market by Type of Drug Molecule (%), 2016
Figure 6-2: Global - Biologic Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 6-3: Global - Small Molecule/Chemical Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 7-1: Global - Psoriasis Drugs Market by Route of Administration (%), 2016
Figure 7-2: Global - Systemic Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 7-3: Global - Topical Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 8-1: Global - Psoriasis Drugs Market by Mechanism of Action (%), 2016
Figure 8-2: Global - TNF Inhibitor Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 8-3: Global - Interleukin Blocker Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 8-4: Global - Other Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 9-1: Global - Psoriasis Drugs Market by Geography (%), 2016
Figure 9-2: North America - Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 9-3: Europe - Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 9-4: Asia-Pacific - Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 14-1: AbbVie Inc. - Revenue by Geography (%), 2015
Figure 14-2: Biocon - Revenue by Business Segments (%), FY 2016
Figure 14-3: Biocon - Revenue by Geography (%), FY 2016
Figure 14-4: Pfizer Inc. - Revenue by Business Segments (%), 2015
Figure 14-5: Pfizer Inc. - Revenue by Geography (%), 2015
Figure 14-6: Novartis - Net Sales by Business Segments (%), 2016
Figure 14-7: Novartis - Net Sales by Geography (%), 2016
Figure 14-8: Eli Lilly and Company - Revenue by Business Segments (%), 2015
Figure 14-9: Eli Lilly and Company - Revenue by Geography (%), 2015
Figure 14-10: Celltrion Inc. - Revenue by Business Segments (%), 2015
Figure 14-11: Celgene Corporation - Revenue by Products (%), 2015
Figure 14-12: Celgene Corporation - Revenue by Geography (%), 2015
Figure 14-13: Johnson & Johnson - Revenue by Business Segments (%), 2015
Figure 14-14: Johnson & Johnson - Revenue by Geography (%), 2015
Figure 14-15: Dr. Reddy’s - Revenue by Business Segments (%), 2016
Figure 14-16: Dr. Reddy’s - Revenue by Geography (%), 2016
Figure 14-17: Amgen Inc. - Revenue by Geography (%), 2015
 
List of Tables:

Table 11-1: Mergers, Acquisitions & Collaborations in Psoriasis Drugs Market (2014-2016)
Table 12-1: Global - Psoriasis Drugs Pipeline Analysis
Table 14-1: AbbVie Inc. - Financials (Million US$), 2013, 2014 & 2015
Table 14-2: Biocon - Financials (Million US$), FY 2014, FY 2015 & FY 2016
Table 14-3: Pfizer Inc. - Financials (Million US$), 2013, 2014 & 2015
Table 14-4: Novartis - Financials (Billion US$),  2014, 2015 & 2016
Table 14-5: Eli Lilly and Company - Financials (Billion US$), 2013, 2014 & 2015
Table 14-6: Celltrion Inc. - Revenue (Billion US$), 2013, 2014 & 2015
Table 14-7: Celgene Corporation - Revenue (Billion US$), 2013, 2014 & 2015
Table 14-8: Johnson & Johnson - Total Sales (Billion US$), 2013, 2014 & 2015
Table 14-9: Dr. Reddy’s - Total Sales (Billion US$), 2014, 2015 & 2016
Table 14-10: Amgen Inc. - Revenue, (Billion US$), 2013, 2014 & 2015"